InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Heinen Mark, Dirigeant. Director active across 1 companies, notably Better Therapeutics, Inc.. Aggregated, 7 filings have been published. Total volume traded: €25k. The latest transaction was disclosed on 24 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
€3,8022,280.605 shares@ €1.667269.75% mcap15.3% of flow
Common Stock
SEC:0000899243-22-024391:0·
Ideal exit: 21 Mar 2023 (T+270)
€7,3455,000 shares@ €1.46929.5% of flow
Common Stock
SEC:0000899243-22-021998:0·
Ideal exit: 7 Mar 2023 (T+270)
€8,9415,000 shares@ €1.788235.9% of flow
Common Stock
SEC:0000899243-22-013344:0·
Ideal exit: 26 Dec 2022 (T+270)
€2,409500 shares@ €4.81844.19% mcap100.0% of flow
Common Stock
SEC:0000899243-21-048374·
Ideal exit: 9 Sept 2022 (T+270)
€2,409500 shares@ €4.81844.19% mcap9.7% of flow
Common Stock
SEC:0000899243-21-048374:0·
Ideal exit: 9 Sept 2022 (T+270)
6,667 shares
Common Stock
SEC:0000899243-21-042247·
6,667 shares
Common Stock
SEC:0000899243-21-042247:0·
7 of 7 declarations
About Heinen Mark
Heinen Mark is an executive at Better Therapeutics, Inc., a health technology company. He contributes to the strategic and operational direction of the company, aiming to develop innovative solutions.
